At Portal, we see the powerful synergy between innovative biotech and medtech startups and federal funding as key to turning this vision into reality. Portal is thrilled to host an incredible series of conversations spotlighting the transformative impact from unique funding opportunities to fuel innovation in life sciences. The Cancer Moonshot is working to end cancer as we know it, with a bold vision to prevent over 4 million cancer deaths by 2047 and radically improve the lives of those touched by cancer. From revolutionary therapies to cutting-edge diagnostic tools, the future of cancer treatment is unfolding before us—and we’re at the forefront of that change.
Join us for an exclusive panel event featuring groundbreaking startups supported by ARPA-H and CancerX, alongside deep-dive discussions with The Cancer Moonshot leadership and industry pioneers. Be part of the conversation that's shaping the future of cancer innovation and patient care.
📆 November 19th, 2024
🕐 8:30 a.m. - 2:30 p.m.
8:30 – 9:00 am | Check-in & Breakfast
9:05 – 9:20 am | Welcome: John Flavin (CEO, Portal) & Monique Knighten (Executive Director, Portal)
9:25 am - 10:10 am | How ARPA-H helps fuel cancer discoveries: Panel discussions with recently-funded startups
10:15 – 10:55 | Session 2: Engaging Capital in New Places and Solutions
11:00 – 11:45 | Session 3: Enabling Innovators through Institutional Partnerships
11:45 am - 12:00pm | Networking Lunch
12:00 – 12:45 | Session 4: Next Gen Catalysts of Change: Emerging Cancer Startups Shaping Tomorrow’s Therapies
1:00 | Session 5: Keynote Fireside: Closing in on the Moon
1:45pm - 2:00pm | Closing, Monique Knighten (Portal), Anabella Aspiras (Cancer Moonshot)
2:00pm - 2:30pm | Tours and coffee